Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral shedding after LAIV in previously vaccinated versus vaccine-naive children
2017-000952-24Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by UK Health Security Agency. Started May 2018; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2017-000952-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000952-24.